Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Raderer

Showing results (161-170 of 264) with videos related to

Pageof 27
Sort By:
Life (Basel, Switzerland)|July 27, 2022
Imaging Inflammation in Atherosclerosis with CXCR4-Directed [<sup>68</sup>Ga]PentixaFor PET/MRI-Compared with [<sup>18</sup>F]FDG PET/MRIXia Lu, Raffaella Calabretta, Wolfgang Wadsak, et al.
Cancers|December 22, 2019
RECIL versus Lugano for Treatment Response Assessment in FDG-Avid Non-Hodgkin Lymphomas: A Head-to-Head Comparison in 54 PatientsDominik Berzaczy, Alexander Haug, Philipp B Staber, et al.
Zeitschrift Fur Gastroenterologie|December 12, 2019
[Neuroendocrine tumors in daily gastroenterology and endoscopy - a practice manual]Walter Spindelböck, Patrizia Katharina Kump, Andreas Püspök, et al.
Melanoma Research|November 30, 2005
Somatostatin receptor scintigraphy with 111In-DOTA-lanreotide and 111In-DOTA-Tyr3-octreotide in patients with stage IV melanoma: in-vitro and in-vivo resultsJulia Valencak, Elisabeth Heere-Ress, Tatjana Traub-Weidinger, et al.
The American Journal of Pathology|February 26, 2004
FAS (CD95) mutations are rare in gastric MALT lymphoma but occur more frequently in primary gastric diffuse large B-cell lymphomaSabine Wohlfart, David Sebinger, Petra Gruber, et al.
Cancer Investigation|February 21, 2002
Randomized phase II study of irinotecan plus mitomycin C vs. oxaliplatin plus mitomycin C in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancerWerner Scheithauer, Gabriela V Kornek, Stefan Brugger, et al.
European Radiology|March 9, 2013
Gadoxetate-enhanced versus diffusion-weighted MRI for fused Ga-68-DOTANOC PET/MRI in patients with neuroendocrine tumours of the upper abdomenMarius E Mayerhoefer, Ahmed Ba-Ssalamah, Michael Weber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2006
Antibiotic treatment is not effective in patients infected with Helicobacter pylori suffering from extragastric MALT lymphomaBirgit Grünberger, Stefan Wöhrer, Berthold Streubel, et al.
International Archives of Allergy and Immunology|September 24, 2005
Cell surface membrane antigen phenotype of human gastrointestinal mast cellsMaria-Theresa Krauth, Yasamin Majlesi, Stefan Florian, et al.
Molecular and Clinical Oncology|March 21, 2014
Lack of correlation between blood group and HER-2 status in adenocarcinomas of the upper gastrointestinal tractMichael Hejna, Peter Birner, Matthias Preusser, et al.
Pageof 27

Showing results (161-170 of 264) with videos related to

Sort By:
Pageof 27
Life (Basel, Switzerland)|July 27, 2022
Imaging Inflammation in Atherosclerosis with CXCR4-Directed [<sup>68</sup>Ga]PentixaFor PET/MRI-Compared with [<sup>18</sup>F]FDG PET/MRIXia Lu, Raffaella Calabretta, Wolfgang Wadsak, et al.
Cancers|December 22, 2019
RECIL versus Lugano for Treatment Response Assessment in FDG-Avid Non-Hodgkin Lymphomas: A Head-to-Head Comparison in 54 PatientsDominik Berzaczy, Alexander Haug, Philipp B Staber, et al.
Zeitschrift Fur Gastroenterologie|December 12, 2019
[Neuroendocrine tumors in daily gastroenterology and endoscopy - a practice manual]Walter Spindelböck, Patrizia Katharina Kump, Andreas Püspök, et al.
Melanoma Research|November 30, 2005
Somatostatin receptor scintigraphy with 111In-DOTA-lanreotide and 111In-DOTA-Tyr3-octreotide in patients with stage IV melanoma: in-vitro and in-vivo resultsJulia Valencak, Elisabeth Heere-Ress, Tatjana Traub-Weidinger, et al.
The American Journal of Pathology|February 26, 2004
FAS (CD95) mutations are rare in gastric MALT lymphoma but occur more frequently in primary gastric diffuse large B-cell lymphomaSabine Wohlfart, David Sebinger, Petra Gruber, et al.
Cancer Investigation|February 21, 2002
Randomized phase II study of irinotecan plus mitomycin C vs. oxaliplatin plus mitomycin C in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancerWerner Scheithauer, Gabriela V Kornek, Stefan Brugger, et al.
European Radiology|March 9, 2013
Gadoxetate-enhanced versus diffusion-weighted MRI for fused Ga-68-DOTANOC PET/MRI in patients with neuroendocrine tumours of the upper abdomenMarius E Mayerhoefer, Ahmed Ba-Ssalamah, Michael Weber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2006
Antibiotic treatment is not effective in patients infected with Helicobacter pylori suffering from extragastric MALT lymphomaBirgit Grünberger, Stefan Wöhrer, Berthold Streubel, et al.
International Archives of Allergy and Immunology|September 24, 2005
Cell surface membrane antigen phenotype of human gastrointestinal mast cellsMaria-Theresa Krauth, Yasamin Majlesi, Stefan Florian, et al.
Molecular and Clinical Oncology|March 21, 2014
Lack of correlation between blood group and HER-2 status in adenocarcinomas of the upper gastrointestinal tractMichael Hejna, Peter Birner, Matthias Preusser, et al.
Pageof 27